DDD-028
DDD-028 is a potent non-opioid, non-cannabinoid analgesic which attenuates neuropathic and inflammatory pain without the possible side effects or abuse potential associated with opioid or cannabinoid activities. DDD-028 can be utilized in analgesic research[1].
Product Specifications
CAS Number
[1538586-09-2]
UNSPSC
12352005
Target
Opioid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/ddd-028.html
Smiles
CN(CC1)CC2=C1N(CC3)C4=C2C=CC=C4C5=C3C=CC=C5
Molecular Formula
C20H20N2
Molecular Weight
288.39
References & Citations
[1]Rajagopalan P, et al. DDD-028: a potent potential non-opioid, non-cannabinoid analgesic for neuropathic and inflammatory pain. Bioorg Med Chem Lett. 2014 Jul 15;24 (14) :3088-91.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1465420-01 0.02 mg (E-Coli)
Recombinant Yersinia pseudotuberculosis Undecaprenyl pyrophosphate synthase (uppS)
Ask
View Details 
MBS1465420-02 0.1 mg (E-Coli)
Recombinant Yersinia pseudotuberculosis Undecaprenyl pyrophosphate synthase (uppS)
Ask
View Details 
MBS1465420-03 0.02 mg (Yeast)
Recombinant Yersinia pseudotuberculosis Undecaprenyl pyrophosphate synthase (uppS)
Ask
View Details MBS1465420-04 0.1 mg (Yeast)
Recombinant Yersinia pseudotuberculosis Undecaprenyl pyrophosphate synthase (uppS)
Ask
View Details MBS1465420-05 0.02 mg (Baculovirus)
Recombinant Yersinia pseudotuberculosis Undecaprenyl pyrophosphate synthase (uppS)
Ask
View Details MBS1465420-06 0.02 mg (Mammalian-Cell)
Recombinant Yersinia pseudotuberculosis Undecaprenyl pyrophosphate synthase (uppS)
Ask
View Details